trial · primary record
Faricimab
Radiation Retinopathy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2029-12-26 |
| Primary endpoint | Change in visual acuity from baseline |
| Registry ID | NCT05844982 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:28.845Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05844982
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.